HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy-Reference-Cited by-同舟云学术

HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy

Published:2024-06-25 Issue:2 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Balci Topuz Beril¹,Sert Fatma²,Sezak Murat³,Soylu Mehmet⁴,Yalman Deniz²,Ozkok Serdar²

Affiliation:

1. Department of Radiation Oncology, Ministry of Health Dr. Ersin Arslan Training and Research Hospital, Gaziantep 27090, Türkiye

2. Department of Radiation Oncology, Ege University Faculty of Medicine, Izmir 35100, Türkiye

3. Department of Pathology, Ege University Faculty of Medicine, Izmir 35100, Türkiye

4. Department of Microbiology, Ege University Faculty of Medicine, Izmir 35100, Türkiye

Publisher

Spandidos Publications

Reference64 articles.

1. SEER cancer statistics factsheets: Anal Cancer;National Cancer Institute

2. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups;Bartelink;J Clin Oncol,1997

3. Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with localized squamous cell carcinoma of the anal canal;Oliveira;J Gastrointest Cancer,2016

4. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: Final analysis of the randomized UNICANCER ACCORD 03 trial;Peiffert;J Clin Oncol,2012

5. clinicalguidelines@esmo.org: Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up*;Rao;Ann Oncol,2021